8-K: AI Technology Group Changes Auditors Amid Accounting Disagreements

Sentiment:

Changes in Registrant's Certifying Accountant


AI Technology Group Inc. has dismissed its auditor, Michael Gillespie & Associates, PLLC, citing disagreements over accounting treatment for a significant acquisition and related loans, and has appointed Fruci & Associates II, PLLC as its new auditor.

Delay expectedThe former auditor did not complete its audit of the company's financial statements for the year ended December 31, 2025, due to unresolved accounting issues.The engagement with the former auditor was terminated before management could provide updated accounting analysis and supporting documentation.
Worse than expectedThe former auditor explicitly disagreed with the company's statement that there were no disagreements or reportable events, indicating that the issues raised were significant and unresolved.The former auditor did not complete the audit for the fiscal year ended December 31, 2025, due to these unresolved matters, suggesting potential complications in the company's financial statements.

Summary

  • AI Technology Group Inc. (AI Tech) has changed its independent registered public accounting firm.
  • The Board of Directors requested the resignation of Michael Gillespie & Associates, PLLC (Gillespie & Associates) on May 7, 2026.
  • Gillespie & Associates raised questions regarding the accounting treatment of a December 15, 2025 agreement where AI Tech acquired 100% of AVM Nevada from Biomed 360 Solutions Corp., including accounting for certain loans of AVM Nevada.
  • These matters were not resolved to Gillespie & Associates' satisfaction before their resignation.
  • Fruci & Associates II, PLLC (Fruci) has been engaged as the new independent auditor, effective August 31, 2026, to audit financial statements for the fiscal year ending December 31, 2025.
  • Gillespie & Associates stated they do not agree with the company's assertion that there were no disagreements or reportable events through the date of resignation, specifically citing unresolved matters related to the Biomed/AVM transaction, related party transactions, and potential legal/regulatory implications.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative development due to the disagreement with the former auditor regarding significant accounting matters and reportable events, indicating potential underlying issues.

Positives

  • The company has appointed a new auditor, Fruci & Associates II, PLLC, to continue the audit for the fiscal year ending December 31, 2025, ensuring continuity in financial reporting.
  • The previous auditor's reports for fiscal years 2023 and 2024 did not contain adverse opinions or disclaimers, other than a going concern paragraph.

Negatives

  • Disagreement with the former auditor, Michael Gillespie & Associates, PLLC, regarding significant accounting matters and reportable events related to the acquisition of AVM Nevada and associated loans.
  • The former auditor did not complete the audit for the fiscal year ended December 31, 2025, due to unresolved issues.
  • The former auditor explicitly stated they do not agree with the company's representation that no disagreements or reportable events existed through the resignation date, highlighting unresolved issues concerning the acquisition, related party transactions, and potential legal/regulatory implications.

Risks

  • Potential for further scrutiny and delays in financial statement audits due to the unresolved accounting issues raised by the former auditor.
  • The "going concern" paragraph in previous audit reports indicates potential financial instability.
  • Unresolved matters regarding related party transactions and potential legal/regulatory implications of credit extensions could pose future risks.
  • The accounting treatment of the acquisition of AVM Nevada and its related loans remains a point of contention.

Future Outlook

The company has engaged a new auditor to complete the audit for the fiscal year ending December 31, 2025, and to conduct ongoing quarterly reviews. The resolution of accounting issues raised by the former auditor will be critical for future financial reporting.

Management Comments

  • The company's accounting assessment of the transaction was preliminary and had not been finalized at the time questions were raised by Gillespie & Associates.
  • The engagement with Gillespie & Associates was terminated before management completed and provided its updated accounting analysis and supporting documentation.

Industry Context

StockSavvy.ai notes that auditor changes, especially those involving disagreements over accounting principles or significant transactions, can be a red flag for investors and may signal underlying financial reporting complexities or weaknesses within a company. This is particularly relevant in the technology and biotech sectors where complex transactions and valuations are common.

Legal Proceedings

  • Potential legal and regulatory implications of extensions of credit were raised as a matter by the former auditor.

Related Party Transactions

  • Transactions and balances involving officers and related parties were raised as a matter by the former auditor.

Stakeholder Impact

  • Shareholders may face uncertainty regarding the timely completion of financial audits and the potential implications of the accounting disagreements.
  • Creditors and investors may require further clarification on the financial health of the company, especially given the prior going concern disclosure.

Next Steps

  • Fruci & Associates II, PLLC will audit the company's financial statements for the fiscal year ending December 31, 2025.
  • Fruci & Associates II, PLLC will conduct reviews of the company's unaudited quarterly financial statements.
  • The company will need to provide necessary documentation and analysis to Fruci & Associates II, PLLC to resolve the accounting issues raised by the former auditor.

Key Dates

DateDescription
2023-12-31Fiscal year end for which audit reports were issued by Gillespie & Associates.
2024-12-31Fiscal year end for which audit reports were issued by Gillespie & Associates.
2025-09-30Interim period through which prior audit procedures were conducted by Gillespie & Associates.
2025-12-15Date of the agreement between AI Tech, Biomed 360 Solutions Corp., and AVM Biotechnology Inc. for the acquisition of AVM Nevada.
2025-12-31Fiscal year end for which Gillespie & Associates did not complete its audit.
2026-05-07Date the Board of Directors requested Gillespie & Associates' resignation and the resignation was tendered.
2026-08-31Effective date of engagement for Fruci & Associates II, PLLC as the new independent auditor.
2026-10-02Date of the Form 8-K filing.

Recommendation

hold

The change in auditors coupled with significant disagreements over accounting treatment for a key acquisition and related loans, alongside a prior going concern disclosure, introduces considerable uncertainty. While a new auditor is engaged, the unresolved issues and potential for further delays or restatements warrant a cautious 'hold' until clarity is achieved on the financial reporting integrity.

Keywords

Auditor Change, Accounting Disagreement, Acquisition Accounting, Related Party Transactions, Going Concern, Form 8-K, Financial Reporting, Audit Procedures

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.